$0.55
+0.01 (+2.06%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where OGEN is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional · 1 with posted results
Held by 1 tracked-famous manager (JANE STREET GROUP, LLC) · FINRA short interest 31.3 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain InjuryNCT06870240Patient symptom reportingQuadruple-masked · Treatment | Phase 2 | Not yet recruiting | Drug: Neurosteroid enantiomer | Mild Traumatic Brain Injury, Concussion | 40 | 2026-01-01 | 2025-03-11 |
| Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per DayNCT03234465results2020-11-23Efficacy of AG013 Compared to Placebo for Reducing OM as Measured by Duration (in Days) of Severe Oral Mucositis (WHO Grades 3 or 4)Randomized · Quadruple-masked · TreatmentStudy Protocol ↗ · Statistical Analysis Plan ↗ | Phase 2 | Terminatedsponsor's stated reason: No efficacy could be demonstrated, sponsor decided to prematurely end the study. | Biological: AG013 · Other: Placebo | Oral Mucositis | 200 | 2020-03-31actual | 2020-11-23 |
| Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)NCT01520974Enumeration of S. mutans in saliva and seven periodontal pathogens in subgingival plaqueRandomized · Triple-masked | Not applicable | Unknown status | Other: ProBiora3 mints, Placebo tablet | Oral Health | 48 | Aug 2012 | 2012-05-02 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19